ALT

Altimmune, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-06

Figures on this page computed 2026-11-08 13:11 UTC

Last close

1.97USD

Market data, 2026-11-05

ALT: weekly closes from 2.85 on 2026-05-15 to 1.97 on 2026-11-05, a move of -30.9%. Prices in USD.

Weekly closes, 2026-05-15 to 2026-11-05

Over that span: -30.9%

Except where said otherwise: 10-K for 2025, filed 2026-03-06

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-06
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-06
- 10-Q for 2025, filed 2026-08-12
The filing itself
-214861.0%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
The filing itself
-164746.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
The filing itself
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-Q for 2025, filed 2026-08-12
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Growth is the furthest below its sector's middle: 0.26 against 0.50 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

0.01x

1.42x

1.61x

5.23x

0.15x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-05

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-06

Sales0.01x
Its own average over 10 years, 4.3M.
Profit1.42x
Its own average over 10 years, -62.0M.
Free cash flow1.61x
Its own average over 9 years, -42.0M.
Debt5.23x
Its own average over 8 years, 6.8M.
Price0.15x
Its own average over 10 years, 13. Market data, 2026-11-05

Debt is furthest from its own average, at 5.23 times.

The filed years, as a table

Each line is 100 at 2016-12-31, the first year we hold.

Filed year	Sales	Shares in issue
2016-12-31	100.0	100.0
2017-12-31	331.8	n/a
2018-12-31	319.2	n/a
2019-12-31	179.3	n/a
2020-12-31	252.9	117.1
2021-12-31	136.3	188.6
2022-12-31	-2.1	214.4
2023-12-31	13.2	243.3
2024-12-31	0.6	324.4
2025-12-31	1.3	402.6

How sales was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001326190-26-000018
Reported in: USD

The filing itself

How shares in issue was got

Source: filed
Statement: income
Fiscal year: 2025
Accession: 0001326190-26-000018
Reported in: USD

The filing itself

Figures behind the shape

Growth

-65.3%

faster is higher, placed against 4,950 companies as of 2026-11-07

Five-year revenue growth rate-65.3%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Five-year EPS growth raten/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
One-year change in net income7.3%
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Returns on capital

-39.2%

higher is higher, placed against 5,089 companies as of 2026-11-07

Return on invested capitaln/a
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-06
- 10-Q for 2025, filed 2026-08-12
The filing itself
Return on equity-39.2%
Net Income / Shareholders' Equity x 100
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-Q for 2025, filed 2026-08-12
The filing itself
Return on assets-31.5%
Net Income / Total Assets x 100
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-Q for 2025, filed 2026-08-12
The filing itself

Margins

-230461.0%

wider is higher, placed against 3,412 companies as of 2026-11-07

Gross marginn/a
We do not hold this figure for this company, so there is nothing to place.
Gross Profit / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
The filing itself
Operating margin-230461.0%
Operating Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
The filing itself
Net margin-214861.0%
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
The filing itself
Free cash flow margin-164746.3%
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
The filing itself

Price

0.8x

cheaper is higher, placed against 4,362 companies as of 2026-11-07

Price to earningsn/a
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-06
The filing itself
Price to book0.8x10-Q for 2025, filed 2026-08-12
Price / Book Value per Share, where BVPS = Shareholders' Equity / Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001326190-26-000052
Reported in
USD
- computed
- 10-Q for 2025, filed 2026-08-12
- computed
- 10-K for 2025, filed 2026-03-06
The filing itself
EV to EBITDAn/a
We do not hold this figure for this company, so there is nothing to place.
Enterprise Value / EBITDA, where EV = Market Cap + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
- 10-Q for 2025, filed 2026-08-12
- 10-K for 2025, filed 2026-03-06
The filing itself
Price to sales ratio4469.7x
Market Cap / Revenue, where Market Cap = Price x Diluted Shares
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
The filing itself

Safety

18.55

safer is higher, placed against 3,227 companies as of 2026-11-07

Debt to equityn/a
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-Q for 2025, filed 2026-08-12
The filing itself
Current ratio18.5510-Q for 2025, filed 2026-08-12
Current Assets / Current Liabilities
Source
computed
Fiscal year
2025
Accession
0001326190-26-000052
Reported in
USD
- 10-Q for 2025, filed 2026-08-12
- 10-Q for 2025, filed 2026-08-12
The filing itself
Interest coveragen/a
We do not hold this figure for this company, so there is nothing to place.
Operating Income / Interest Expense
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
The filing itself
Altman Z-Score-1.24
1.2 x A + 1.4 x B + 3.3 x C + 0.6 x D + 1.0 x E (A=WC/TA, B=RE/TA, C=EBIT/TA, D=MktCap/TL, E=Rev/TA)
Source
computed
Taken on
2026-11-07
Reported in
USD
- Computed from the 10-K for 2025, filed 2026-03-06
- Computed from the 10-K for 2025, filed 2026-03-06
- Computed from the 10-K for 2025, filed 2026-03-06
- Computed from the 10-K for 2025, filed 2026-03-06
- Computed from the 10-K for 2025, filed 2026-03-06

What it pays out

n/a

We do not hold this figure for this company, so there is nothing to place.

more, and better covered, is higher, with no cohort held

Dividend yieldn/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
Payout ration/a
We do not hold this figure for this company, so there is nothing to place.
Common Dividends Paid / Net Income x 100, both from the latest filed fiscal year
Source
computed
Fiscal year
2025
Accession
0001326190-26-000018
Reported in
USD
- 10-K for 2025, filed 2026-03-06
- Computed from the 10-K for 2025, filed 2026-03-06
- 10-K for 2025, filed 2026-03-06
The filing itself
Dividend cover ration/a
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Share a finding

A link to the finding, not to you: it carries nothing about your account.